Organogenesis Holdings Inc. (ORGO) — Financial statements
Income statement, balance sheet, and cash flow for Organogenesis Holdings Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 563↑16.8% | 482↑11.3% | 433↓3.9% | 451↓3.5% | 467 | |
| Cost of Revenue | 138↑18.8% | 116↑8.7% | 106↑1.4% | 105↓8.0% | 114 | |
| Gross Profit | 426↑16.2% | 366↑12.1% | 327↓5.6% | 346↓2.1% | 353 | |
| Operating Expenses | ||||||
| R&D Expenses | 45↓11.4% | 50↑13.3% | 44↑11.6% | 40↑29.3% | 31 | |
| General & Administrative Expenses | 0.00↓100.0% | 291↑9.9% | 265↓5.2% | 279 | 0.00 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 4↓26.8% | 5↑8.6% | 5 | 0.00 | |
| SG&A Expenses | 326↑10.8% | 295↑9.2% | 270↓5.0% | 284↑13.4% | 250 | |
| Other Expenses | -1↓105.0% | 23 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 370↑0.6% | 368↑17.0% | 314↓2.9% | 324↑15.2% | 281 | |
| Total Costs & Expenses | 507↑4.9% | 483↑14.9% | 421↓1.9% | 429↑8.5% | 395 | |
| Operating Results | ||||||
| Operating Income | 56↑4454.6% | -1↓110.2% | 13↓43.8% | 22↓69.1% | 72 | |
| Depreciation & Amortization | 27↑58.2% | 17↓27.4% | 23↑30.0% | 18↑8.1% | 17 | |
| EBITDA | 83↑425.3% | 16↓56.3% | 36↓10.6% | 40↓53.7% | 87 | |
| EBIT | 56↑4523.5% | -1↓110.0% | 13↓43.6% | 22↓68.3% | 70 | |
| Interest & Other Income | ||||||
| Net Interest Income | 2↑247.7% | -2↑29.5% | -2↓9.0% | -2↑72.2% | -7 | |
| Interest Income | 2 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00↓100.0% | 2↓29.5% | 2↑9.0% | 2↓72.2% | 7 | |
| Non-Operating Income | 0.00↑100.0% | -0.02↑64.9% | -0.06↓538.5% | 0.01↓99.3% | 2 | |
| Other Income / Expenses | -9↓483.9% | -2↑28.6% | -2↓5.5% | -2↑77.9% | -9 | |
| Income Before Tax | 47↑1773.3% | -3↓127.0% | 10↓48.8% | 20↓67.9% | 63 | |
| Income Tax Expense | 10↑370.9% | -4↓167.3% | 5↑14.7% | 5↑115.3% | -31 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 37↑4201.0% | 0.86↓82.6% | 5↓68.2% | 16↓83.5% | 94 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 37↑4201.0% | 0.86↓82.6% | 5↓68.2% | 16↓83.5% | 94 | |
| Bottom-Line Net Income | 20↑2236.8% | -0.94↓118.9% | 5↓68.2% | 16↓83.5% | 94 | |
| EPS (Basic) | 0.16↑2353.5% | -0.01↓118.8% | 0.04↓68.6% | 0.12↓83.6% | 0.73 | |
| EPS (Diluted) | 0.15↑1600.0% | -0.01↓126.8% | 0.04↓68.9% | 0.12↓82.9% | 0.70 | |
| Weighted Average Shares | 127↓3.7% | 132↑0.3% | 131↑0.9% | 130↑1.4% | 128 | |
| Weighted Average Diluted Shares | 130↓1.1% | 132↓0.8% | 133↑0.3% | 132↓1.0% | 134 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.